Keywords: baxter, vaccine, combat, group, meningococci, international, started

Baxter vaccine to combat group B meningococci

Article | 22 March 2001

Print This

Baxter International has started Phase I clinical trials in Belgium ofa new vaccine designed to prevent meningitis caused by Neisseria ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in